Gian Piero Ricciuti
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Gian Piero Ricciuti has a total of 60 co-authors. Here are the top co-authors by number of shared publications:
- Alessandro Sciarra
Department of Maternal-Infant and Urological Sciences, “Sapienza” University of Rome, Umberto I Hospital, 00185 Rome, Italy
5 shared publications - Stefano Salciccia
Sapienza University of Rome
5 shared publications - Ettore De Berardinis
Department of Maternal-Infant and Urological Sciences, “Sapienza” University of Rome, Umberto I Hospital, 00185 Rome, Italy
4 shared publications - Francesco Del Giudice
Department of Engineering, University of Basilicata, Ateneo Lucano Avenue 10, 85100 Potenza, Italy
4 shared publications - Gian Maria Busetto
Department of Urology and Renal Transplantation, University of Foggia, 71122, Foggia, Italy
3 shared publications - Martina Maggi
Department of Urology, Department of Health Science, University of Milan, ASST Santi Paolo e Carlo, Milan, Italy
3 shared publications
Latest Publications
- Open Access
- 24 January 2026
- Published by Springer Nature in Research Square
Dynamic evaluation of metabolic syndrome and its impact on surgical outcomes after Retrograde Intrarenal Surgery (RIRS): an academic single-center retrospective study
Purpose To evaluate their impact on surgical outcomes, such as stone-free rate, consequent need for a second surgery and perioperative complications in patients submitted to RIRS. Patients and Methods A single-center retrospective study including adult patients undergoing RIRS. Exclusion criteria were abnormal urinary tract anatomy, bilateral or concomitant ureteral stone surgery. Clinical and surgical characteristics were collected. Stone free status was defined as no clinically relevant residual fragments (> 2mm) at 3-months after surgery. Group comparison and logistic regression were studied to assess predictors and surgical outcomes Results 120 patients (63 men and 57 women) who underwent RIRS were included. Mean age was 54.0 (± 13.2). 37 (30.8%) cases were classified as FMD, 49 (40.9%) as MMD and 34 (28.3%) as MetS. Stone free (SF+) rate in the general population was 55.8% and 64.9%, 57.1%, 44.1% in FMD, MMD and Mets patients, respectively. Patients no stone free (SF-) presented a higher prevalence of diabetes in comparison to SF + cases (p = 0.002). Patients who needed a second procedure (40%) to eliminate residual ureteral fragments presented a higher prevalence of diabetes (58.3% vs. 30.6%,p = 0.005) and hypertriglyceridemia (41.7% vs. 20.8%, p = 0.024). At univariate analysis diabetes resulted to be a significant predictor of no stone free status at 3 months (OR 3.56, 95% C.I. 1.681–7.757, p-value = 0.001) and for the need of second surgery (OR 3.182, 95% C.I. 1.500–6.919,p-value = 0.003). Conclusion Diabetes appears to be a significant risk factor for poor outcomes after RIRS. Our results may be relevant during patient counselling and surgery planning.
- 24 January 2026
- Published by Springer Nature in Research Square
Open AccessDynamic evaluation of metabolic syndrome and its impact on surgical outcomes after Retrograde Intrarenal Surgery (RIRS): an academic single-center retrospective study
Purpose To evaluate their impact on surgical outcomes, such as stone-free rate, consequent need for a second surgery and perioperative complications in patients submitted to RIRS. Patients and Methods A single-center retrospective study including adult patients undergoing RIRS. Exclusion criteria were abnormal urinary tract anatomy, bilateral or concomitant ureteral stone surgery. Clinical and surgical characteristics were collected. Stone free status was defined as no clinically relevant residual fragments (> 2mm) at 3-months after surgery. Group comparison and logistic regression were studied to assess predictors and surgical outcomes Results 120 patients (63 men and 57 women) who underwent RIRS were included. Mean age was 54.0 (± 13.2). 37 (30.8%) cases were classified as FMD, 49 (40.9%) as MMD and 34 (28.3%) as MetS. Stone free (SF+) rate in the general population was 55.8% and 64.9%, 57.1%, 44.1% in FMD, MMD and Mets patients, respectively. Patients no stone free (SF-) presented a higher prevalence of diabetes in comparison to SF + cases (p = 0.002). Patients who needed a second procedure (40%) to eliminate residual ureteral fragments presented a higher prevalence of diabetes (58.3% vs. 30.6%,p = 0.005) and hypertriglyceridemia (41.7% vs. 20.8%, p = 0.024). At univariate analysis diabetes resulted to be a significant predictor of no stone free status at 3 months (OR 3.56, 95% C.I. 1.681–7.757, p-value = 0.001) and for the need of second surgery (OR 3.182, 95% C.I. 1.500–6.919,p-value = 0.003). Conclusion Diabetes appears to be a significant risk factor for poor outcomes after RIRS. Our results may be relevant during patient counselling and surgery planning.
- Open Access
- 22 October 2022
- Published by MDPI AG in Applied Sciences
- Vol. 12 (21) , 10718
Characteristics of Sepsis or Acute Pyelonephritis Combined with Ureteral Stone in the United States: A Retrospective Analysis of Large National Cohort
To identify the characteristics of patients with sepsis or acute pyelonephritis (APN) combined with ureteral calculi and to analyze the risk factors in its causation. Methods: We included patients with sepsis or APN caused by ureteral calculi who received treatment in the United States from January 2003 to December 2017 using the Optum® deidentified Clinformatics® Datamart. Demographic factors and risk factors for the receipt of sepsis or APN were subsequently analyzed for statistical significance. Results: Of 467,502 urinary stone patients, age-matched multivariate analysis revealed that a history of urinary tract infection (OR 11.31, 95% CI 10.68–11.99, p < 0.0001) and female gender (OR 2.73, 95% CI 2.62–2.84, p < 0.0001) were significantly related to an increased risk of sepsis or APN. Conversely, a previous past medical history of urolithiasis (OR 0.91, 95% CI 0.87–0.95, p < 0.0001) and cancer (OR 0.91, 95% CI 0.87–0.95, p < 0.0001) were associated with a decreased risk of sepsis or APN. With regards to comorbidities, when more than one comorbidity was present, there was an additive effect with higher OR point estimates, rising to 11.31 (10.68–11.99) when three or more comorbidities present. History of urinary tract infection and female gender are risk factors for sepsis or APN in patients with ureteral calculi. Conclusions: This large national cohort reveals the characteristics of sepsis or APN combined with ureteral stone and provides an important baseline for the treatment of urolithiasis in the future.
- 22 October 2022
- Published by MDPI AG in Applied Sciences
- Vol. 12 (21) , 10718
Open AccessCharacteristics of Sepsis or Acute Pyelonephritis Combined with Ureteral Stone in the United States: A Retrospective Analysis of Large National Cohort
To identify the characteristics of patients with sepsis or acute pyelonephritis (APN) combined with ureteral calculi and to analyze the risk factors in its causation. Methods: We included patients with sepsis or APN caused by ureteral calculi who received treatment in the United States from January 2003 to December 2017 using the Optum® deidentified Clinformatics® Datamart. Demographic factors and risk factors for the receipt of sepsis or APN were subsequently analyzed for statistical significance. Results: Of 467,502 urinary stone patients, age-matched multivariate analysis revealed that a history of urinary tract infection (OR 11.31, 95% CI 10.68–11.99, p < 0.0001) and female gender (OR 2.73, 95% CI 2.62–2.84, p < 0.0001) were significantly related to an increased risk of sepsis or APN. Conversely, a previous past medical history of urolithiasis (OR 0.91, 95% CI 0.87–0.95, p < 0.0001) and cancer (OR 0.91, 95% CI 0.87–0.95, p < 0.0001) were associated with a decreased risk of sepsis or APN. With regards to comorbidities, when more than one comorbidity was present, there was an additive effect with higher OR point estimates, rising to 11.31 (10.68–11.99) when three or more comorbidities present. History of urinary tract infection and female gender are risk factors for sepsis or APN in patients with ureteral calculi. Conclusions: This large national cohort reveals the characteristics of sepsis or APN combined with ureteral stone and provides an important baseline for the treatment of urolithiasis in the future.
- Open Access
- 22 April 2021
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (9) , 4367
Biomarkers in Prostate Cancer Diagnosis: From Current Knowledge to the Role of Metabolomics and Exosomes
Early detection of prostate cancer (PC) is largely carried out using assessment of prostate-specific antigen (PSA) level; yet it cannot reliably discriminate between benign pathologies and clinically significant forms of PC. To overcome the current limitations of PSA, new urinary and serum biomarkers have been developed in recent years. Although several biomarkers have been explored in various scenarios and patient settings, to date, specific guidelines with a high level of evidence on the use of these markers are lacking. Recent advances in metabolomic, genomics, and proteomics have made new potential biomarkers available. A number of studies focused on the characterization of the specific PC metabolic phenotype using different experimental approaches has been recently reported; yet, to date, research on metabolomic application for PC has focused on a small group of metabolites that have been known to be related to the prostate gland. Exosomes are extracellular vesicles that are secreted from all mammalian cells and virtually detected in all bio-fluids, thus allowing their use as tumor biomarkers. Thanks to a general improvement of the technical equipment to analyze exosomes, we are able to obtain reliable quantitative and qualitative information useful for clinical application. Although some pilot clinical investigations have proposed potential PC biomarkers, data are still preliminary and non-conclusive.
- 22 April 2021
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (9) , 4367
Open AccessBiomarkers in Prostate Cancer Diagnosis: From Current Knowledge to the Role of Metabolomics and Exosomes
Early detection of prostate cancer (PC) is largely carried out using assessment of prostate-specific antigen (PSA) level; yet it cannot reliably discriminate between benign pathologies and clinically significant forms of PC. To overcome the current limitations of PSA, new urinary and serum biomarkers have been developed in recent years. Although several biomarkers have been explored in various scenarios and patient settings, to date, specific guidelines with a high level of evidence on the use of these markers are lacking. Recent advances in metabolomic, genomics, and proteomics have made new potential biomarkers available. A number of studies focused on the characterization of the specific PC metabolic phenotype using different experimental approaches has been recently reported; yet, to date, research on metabolomic application for PC has focused on a small group of metabolites that have been known to be related to the prostate gland. Exosomes are extracellular vesicles that are secreted from all mammalian cells and virtually detected in all bio-fluids, thus allowing their use as tumor biomarkers. Thanks to a general improvement of the technical equipment to analyze exosomes, we are able to obtain reliable quantitative and qualitative information useful for clinical application. Although some pilot clinical investigations have proposed potential PC biomarkers, data are still preliminary and non-conclusive.
- 1 April 2021
- Published by SAGE Publications in Journal of Endourology
- Vol. 35 (4) , 395-408
Safety and Feasibility of Outpatient Surgery in Benign Prostatic Hyperplasia: a Systematic Review and Meta-Analysis
Purpose: Most of the endourologic procedures along the urinary tract have been widely practiced as outpatient operations, including surgery for benign prostatic hyperplasia (BPH). This systematic review and meta-analysis was conducted to assess safety and feasibility of outpatient surgery for patients suffering from symptomatic BPH candidate for endoscopic disobstruction. Materials and Methods: PubMed, Web of Science, Cochrane, and Embase were searched up until March 30, 2020. Methodological index for nonrandomized studies (MINORS) tool was utilized to assess the quality of included studies, and a pooled measure of failure rate (FR) or event rate (ER) estimate was calculated. Further sensitivity analysis, subgroup analysis, and meta-regression were conducted to investigate contribution of moderators to heterogeneity. Results: Twenty studies with a total of 1626 patients treated according to outpatient criteria for endoscopic BPH surgery were included. In total, 18 studies reporting data on immediate hospital readmission and/or inability to discharge after endoscopic procedure presented FR estimates ranging from 1.7% to 51.1%. Pooled FR estimate was 7.8% (95% confidence interval [CI]: 5.2–10.3); Heterogeneity: Q = 76.85; degree of freedom = 17, p < 0.001; I 2 = 75.12%. Subgroup analysis according to surgical technique revealed difference among the three approaches with pooled FR of 3% (95% CI: 1–4.9), 7.1% (95% CI: 3.9–10.4), and 11.8% (95% CI: 7–16.7) for transurethral resection of the prostate, Green-light, and holmium laser vaporesection, respectively ( p < 0.001). At meta-regression analysis, none of the retrieved covariates was able to significantly influence the cumulative outcomes reported. ER for postoperative complications and early outpatient visit showed a pooled estimate of 18.6% (95% CI: 13.2–23.9) and 7.7% (95% CI: 4.3–11), respectively. Conclusions: Our analysis revealed how transurethral procedures for BPH on an outpatient setting are overall reliable and safe. Of note, there were significant outcome differences between groups with regard to type of surgical procedure, perioperative prostate volume, and discharge protocol suggesting the need for further prospective analysis to better elucidate the best strategy in such outpatient conduct.
- 1 April 2021
- Published by SAGE Publications in Journal of Endourology
- Vol. 35 (4) , 395-408
Safety and Feasibility of Outpatient Surgery in Benign Prostatic Hyperplasia: a Systematic Review and Meta-Analysis
Purpose: Most of the endourologic procedures along the urinary tract have been widely practiced as outpatient operations, including surgery for benign prostatic hyperplasia (BPH). This systematic review and meta-analysis was conducted to assess safety and feasibility of outpatient surgery for patients suffering from symptomatic BPH candidate for endoscopic disobstruction. Materials and Methods: PubMed, Web of Science, Cochrane, and Embase were searched up until March 30, 2020. Methodological index for nonrandomized studies (MINORS) tool was utilized to assess the quality of included studies, and a pooled measure of failure rate (FR) or event rate (ER) estimate was calculated. Further sensitivity analysis, subgroup analysis, and meta-regression were conducted to investigate contribution of moderators to heterogeneity. Results: Twenty studies with a total of 1626 patients treated according to outpatient criteria for endoscopic BPH surgery were included. In total, 18 studies reporting data on immediate hospital readmission and/or inability to discharge after endoscopic procedure presented FR estimates ranging from 1.7% to 51.1%. Pooled FR estimate was 7.8% (95% confidence interval [CI]: 5.2–10.3); Heterogeneity: Q = 76.85; degree of freedom = 17, p < 0.001; I 2 = 75.12%. Subgroup analysis according to surgical technique revealed difference among the three approaches with pooled FR of 3% (95% CI: 1–4.9), 7.1% (95% CI: 3.9–10.4), and 11.8% (95% CI: 7–16.7) for transurethral resection of the prostate, Green-light, and holmium laser vaporesection, respectively ( p < 0.001). At meta-regression analysis, none of the retrieved covariates was able to significantly influence the cumulative outcomes reported. ER for postoperative complications and early outpatient visit showed a pooled estimate of 18.6% (95% CI: 13.2–23.9) and 7.7% (95% CI: 4.3–11), respectively. Conclusions: Our analysis revealed how transurethral procedures for BPH on an outpatient setting are overall reliable and safe. Of note, there were significant outcome differences between groups with regard to type of surgical procedure, perioperative prostate volume, and discharge protocol suggesting the need for further prospective analysis to better elucidate the best strategy in such outpatient conduct.
- Open Access
- 24 March 2021
- Published by MDPI AG in Diagnostics
- Vol. 11 (4) , 581
Modeling the Contribution of Male Testosterone Levels to the Duration of Positive COVID Testing among Hospitalized Male COVID-19 Patients
Background: A growing body of evidence is emerging suggesting testosterone can affect all cells involved in the immune response to both bacterial and viral infections, and the testosterone effect on the immune response could explain the greater susceptibility of men to infections including COVID-19. We aimed to explore the predictive role of male serum total testosterone (TT) levels on the time till viral negativity testing among hospitalized COVID-19 patients. Methods: The univariate effect of risk factors for the duration of COVID-19 viral positivity was evaluated using the log-rank test and Kaplan–Meier estimates. A multivariable Cox regression model was developed to test the role of TT levels and the subsequent odds for shorter viral positivity intervals. Results: Increasing serum TT levels and the need for an oxygen administration strategy were independently predictive for respectively reduced and increased days to negativization (Hazard Ratio [HR]: 1.39, 95% CI: 0.95–2.03 and HR: 0.19, 95% CI: 0.03–1.18). Conclusion: Baseline higher TT levels for male COVID-19 patients at hospital admission are associated with shorter durations of positive COVID-19 testing and thus viral clearance. Our preliminary findings might play a relevant to help pandemic control strategies if these will be verified in future larger multicentric and possibly randomized trials.
- 24 March 2021
- Published by MDPI AG in Diagnostics
- Vol. 11 (4) , 581
Open AccessModeling the Contribution of Male Testosterone Levels to the Duration of Positive COVID Testing among Hospitalized Male COVID-19 Patients
Background: A growing body of evidence is emerging suggesting testosterone can affect all cells involved in the immune response to both bacterial and viral infections, and the testosterone effect on the immune response could explain the greater susceptibility of men to infections including COVID-19. We aimed to explore the predictive role of male serum total testosterone (TT) levels on the time till viral negativity testing among hospitalized COVID-19 patients. Methods: The univariate effect of risk factors for the duration of COVID-19 viral positivity was evaluated using the log-rank test and Kaplan–Meier estimates. A multivariable Cox regression model was developed to test the role of TT levels and the subsequent odds for shorter viral positivity intervals. Results: Increasing serum TT levels and the need for an oxygen administration strategy were independently predictive for respectively reduced and increased days to negativization (Hazard Ratio [HR]: 1.39, 95% CI: 0.95–2.03 and HR: 0.19, 95% CI: 0.03–1.18). Conclusion: Baseline higher TT levels for male COVID-19 patients at hospital admission are associated with shorter durations of positive COVID-19 testing and thus viral clearance. Our preliminary findings might play a relevant to help pandemic control strategies if these will be verified in future larger multicentric and possibly randomized trials.